Drug-Induced Conformational Dynamics of P-Glycoprotein Underlies the Transport of Camptothecin Analogs
Open Access
- 7 November 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (22) , 16058
Abstract
P-glycoprotein (Pgp) plays a pivotal role in drug bioavailability and multi-drug resistance development. Understanding the protein’s activity and designing effective drugs require insight into the mechanisms underlying Pgp-mediated transport of xenobiotics. In this study, we investigated the drug-induced conformational changes in Pgp and adopted a conformationally-gated model to elucidate the Pgp-mediated transport of camptothecin analogs (CPTs). While Pgp displays a wide range of conformations, we simplified it into three model states: ‘open-inward’, ‘open-outward’, and ‘intermediate’. Utilizing acrylamide quenching of Pgp fluorescence as a tool to examine the protein’s tertiary structure, we observed that topotecan (TPT), SN-38, and irinotecan (IRT) induced distinct conformational shifts in the protein. TPT caused a substantial shift akin to AMPPNP, suggesting ATP-independent ‘open-outward’ conformation. IRT and SN-38 had relatively moderate effects on the conformation of Pgp. Experimental atomic force microscopy (AFM) imaging supports these findings. Further, the rate of ATPase hydrolysis was correlated with ligand-induced Pgp conformational changes. We hypothesize that the separation between the nucleotide-binding domains (NBDs) creates a conformational barrier for substrate transport. Substrates that reduce the conformational barrier, like TPT, are better transported. The affinity for ATP extracted from Pgp-mediated ATP hydrolysis kinetics curves for TPT was about 2-fold and 3-fold higher than SN-38 and IRT, respectively. On the contrary, the dissociation constants (KD) determined by fluorescence quenching for these drugs were not significantly different. Saturation transfer double difference (STDD) NMR of TPT and IRT with Pgp revealed that similar functional groups of the CPTs are accountable for Pgp-CPTs interactions. Efforts aimed at modifying these functional groups, guided by available structure-activity relationship data for CPTs and DNA-Topoisomerase-I complexes, could pave the way for the development of more potent next-generation CPTs.Keywords
Funding Information
- National Institutes of Health (1R01CA204846-01A1, 2122027)
- National Science Foundation (1R01CA204846-01A1, 2122027)
- Research Excellence Program (REP) at the University of Missouri (1R01CA204846-01A1, 2122027)
This publication has 119 references indexed in Scilit:
- Multiple Transport-Active Binding Sites Are Available for a Single Substrate on Human P-Glycoprotein (ABCB1)PLOS ONE, 2013
- P-Glycoprotein-ATPase Modulation: The Molecular MechanismsBiophysical Journal, 2012
- Conformational Analysis of Human ATP-binding Cassette Transporter ABCB1 in Lipid Nanodiscs and Inhibition by the Antibodies MRK16 and UIC2Journal of Biological Chemistry, 2011
- NMR-Derived Models of Amidopyrine and Its Metabolites in Complexes with Rabbit Cytochrome P450 2B4 Reveal a Structural Mechanism of Sequential N-DealkylationBiochemistry, 2011
- Characterization of an Asymmetric Occluded State of P-glycoprotein with Two Bound NucleotidesJournal of Biological Chemistry, 2010
- Flexibility in the ABC transporter MsbA: Alternating access with a twistProceedings of the National Academy of Sciences, 2007
- Protein Structural Variation in Computational Models and Crystallographic DataStructure, 2007
- Conformational and functional characterization of trapped complexes of the P-glycoprotein multidrug transporterBiochemical Journal, 2006
- The Remarkable Transport Mechanism of P-Glycoprotein: A Multidrug TransporterJournal of Bioenergetics and Biomembranes, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005